Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes.
Reproduction of Trypanosoma cruzi epimastigotes in a liver infusion-tryptose-serum medium was inhibited by the antimycotic agent ketoconazole. Effective drug concentrations also blocked the biosynthesis of the parasite's fungal-type sterols at the stage of C-14 demethylation, as demonstrated by radioisotopic, chromatographic and mass spectrometric methods. Coincidently, a 4,4,14 alpha-trimethyl sterol, 24-methylenedihydrolanosterol, accumulated and came to replace as much as three fourths of the free sterol content of the cells. Precedents from studies with fungi are invoked to suggest that the cytotoxicity of ketoconazole for T. cruzi is a consequence of the inability of 24-methylenedihydrolanosterol to perform the membrane lipid bilayer functions of the normal epimastigote sterols.
D000818:Animals; D002855:Chromatography, Thin Layer; D007654:Ketoconazole / Q000494:pharmacology*; D007810:Lanosterol / Q000031:analogs & derivatives / Q000378:metabolism; D013261:Sterols / Q000096:biosynthesis*; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000378:metabolism*
D013261:Sterols; D007810:Lanosterol; C014520:ebericol; D007654:Ketoconazole